France Landry - Cannara Biotech Vice Resources

All Insiders . Canada . 
Stock . Cannara Biotech . Stakeholders . Insider . France Landry
LOVE Stock  CAD 0.75  0.05  6.25%   

Executive

France Landry is Vice Resources of Cannara Biotech
Address 333 Decarie Blvd., Saint-Laurent, QC, Canada, H4N 3M9
Phone514 543 4200
Webhttps://cannara.ca

Cannara Biotech Management Efficiency

The company has return on total asset (ROA) of 0.0378 % which means that it generated a profit of $0.0378 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0678 %, meaning that it generated $0.0678 on every $100 dollars invested by stockholders. Cannara Biotech's management efficiency ratios could be used to measure how well Cannara Biotech manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to 0.04 in 2024. Return On Capital Employed is likely to climb to 0.08 in 2024. At this time, Cannara Biotech's Intangible Assets are fairly stable compared to the past year. Return On Tangible Assets is likely to climb to 0.04 in 2024, whereas Net Tangible Assets are likely to drop slightly above 50.7 M in 2024.
Cannara Biotech has accumulated 5.97 M in total debt with debt to equity ratio (D/E) of 0.45, which is about average as compared to similar companies. Cannara Biotech has a current ratio of 2.89, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Cannara Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Cannara Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cannara Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cannara to invest in growth at high rates of return. When we think about Cannara Biotech's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 13 records

EXECUTIVE Age

Michel GallandLion Electric Corp
N/A
Dominik BeckmanLion Electric Corp
N/A
Monika MascittiRubicon Organics
N/A
Mathieu AubinRubicon Organics
N/A
David SicotteLion Electric Corp
N/A
Nate BaguioLion Electric Corp
N/A
Maxime GauvinLion Electric Corp
N/A
Chris StillRubicon Organics
N/A
Vince SpadaforaLion Electric Corp
N/A
Rocco MezzatestaLion Electric Corp
N/A
Dominique PerronLion Electric Corp
N/A
Richard CoulombeLion Electric Corp
N/A
Isabelle AdjahiLion Electric Corp
N/A
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. The company was incorporated in 2017 and is headquartered in Montreal, Canada. CANNARA BIOTECH is traded on Commodity Exchange in Exotistan. Cannara Biotech (LOVE) is traded on TSX Venture Exchange in Canada and employs 10 people. Cannara Biotech is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Return On Equity0.0678
Return On Asset0.0378

Cannara Biotech Leadership Team

Elected by the shareholders, the Cannara Biotech's board of directors comprises two types of representatives: Cannara Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cannara. The board's role is to monitor Cannara Biotech's management team and ensure that shareholders' interests are well served. Cannara Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cannara Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Abitbol, Vice Marketing
France Landry, Vice Resources
Zohar Krivorot, CEO Chairman
Avi Krivorot, Chief Officer
Scott Carroll, Vice Sales
Anthony Manouk, VP GM
Brian Sherman, General Affairs
Julia Bouvet, Chief Staff
Etienne Ledoux, Executive Officer
Alexander Wolfe, VP Devel

Cannara Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cannara Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Number Of Shares Shorted10

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cannara Stock Analysis

When running Cannara Biotech's price analysis, check to measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY